Related Experiment Videos
Antimalarial activity in Xylocarpus granatum (Koen)
Vijai Lakshmi1, Shishir Srivastava, Sunil Kumar Mishra
1Medicinal and Process Chemistry Division, Central Drug Research Institute, Lucknow-226001, India. vijai_lakshmi@cdri.res.in
Natural Product Research
|July 27, 2011
Summary
Xylocarpus granatum fruit extracts show antimalarial potential against Plasmodium falciparum in vitro. Key compounds, gedunin and xyloccensin-I, exhibit significant activity, validating the plant
Area of Science:
- Pharmacognosy
- Medicinal Chemistry
- Parasitology
Background:
- Malaria remains a significant global health challenge, necessitating the discovery of novel antimalarial agents.
- Natural products, particularly from plants, are a rich source of potential drug candidates.
- Xylocarpus granatum is a mangrove species traditionally used for medicinal purposes.
Purpose of the Study:
- To investigate the antimalarial activity of Xylocarpus granatum fruit extracts.
- To identify and characterize the active compounds responsible for the observed antimalarial effects.
- To evaluate the in vitro efficacy of isolated compounds against Plasmodium falciparum.
Main Methods:
- Extraction and fractionation of Xylocarpus granatum fruits using chloroform.
- In vitro testing of extracts and fractions against Plasmodium falciparum.
- Isolation and structural elucidation of pure compounds from the active fraction using chromatographic and spectroscopic techniques.
Main Results:
- The chloroform fraction of Xylocarpus granatum fruits demonstrated significant in vitro antimalarial activity.
- Four compounds were isolated: gedunin, photogedunin, xyloccensin-I, and palmitic acid.
- Gedunin and xyloccensin-I exhibited antimalarial activity comparable to the parent active fraction.
Conclusions:
- Xylocarpus granatum fruits possess promising antimalarial properties.
- Gedunin and xyloccensin-I are key active constituents contributing to the antimalarial efficacy of X. granatum.
- Further research into these compounds could lead to the development of new antimalarial drugs.